These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3010858)

  • 1. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
    Reefschläger J; Wutzler P; Thiel KD; Herrmann G
    Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
    Reefschläger J; Wutzler P; Thiel KD; Herrmann G
    Pharm Res; 1987 Jun; 4(3):200-6. PubMed ID: 2855541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
    Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
    Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
    Reefschläger J; Bärwolff D; Herrmann G; Langen P
    Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
    Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
    Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
    Färber I; Klinger C; Wutzler P; Thiel KD; Reefschläger J; Herrmann G
    Acta Virol; 1987 Jan; 31(1):13-8. PubMed ID: 2883852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J; Reefschläger J
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
    Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA
    Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
    Machida H; Ikeda T; Ashida N
    Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
    Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
    Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.
    Lin JC; Machida H
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1068-72. PubMed ID: 2847639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
    Machida H; Sakata S
    Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
    Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
    J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
    Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
    Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
    Park NH; Pavan-Langston D; de Clercq E
    Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
    Freeman DJ; Sacks SL; De Clercq E; Spruance SL
    Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulence.
    Machida H; Takezawa J
    Antimicrob Agents Chemother; 1990 May; 34(5):691-6. PubMed ID: 2163240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.
    Reefschläger J; Pein CD; Cech D
    J Med Chem; 1988 Feb; 31(2):393-7. PubMed ID: 2828623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.